W. Bradford Smith

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bedford, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jason Cavalier, Attorney-in-Fact for W. Bradford Smith
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for W. Bradford Smith

Form 4 holding Chief Financial and Business Officer and Treasurer

Homology Medicines, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
213,000
Estimated value
$2,858,460
Report date
23 Feb 2023
Price
$13.42
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial and Business Officer and Treasurer

Homology Medicines, Inc.

Security class
Restricted Stock Units
Shares / value
36,000
Estimated value
$41,407
Report date
23 Feb 2023
Price
$1.15
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Lyra Therapeutics, Inc.

Security class
Stock Option
Shares / value
30,000
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by W. Bradford Smith

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .